Martine Poelman, MD, is executive medical director of oncology for Labcorp Clinical Development Services, based in Brussels, Belgium. She provides medical and scientific support to help advance drug development in hematological malignancies for Labcorp clients. Dr. Poelman brings more than 30 years of experience in clinical research and development as a physician and medical director, specializing in pediatrics and oncology, to Labcorp. Before assuming her current position, Dr. Poelman served more than 15 years as global head of oncology research for Labcorp, providing medical monitoring for more than 200 clinical trials. Before joining Labcorp, she served as clinical research physician for hemato-oncology-infectiology at Eli Lilly in Brussels. Before going into research, she served as bone marrow transplantation and hemato-oncology physician for the department of pediatric oncology, Wilhelmina Children's Hospital, in the Netherlands. She joined Labcorp in November 1996.